{"gene":"EIF2AK2","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1999,"finding":"PKR is activated by binding to dsRNA via a mechanism involving autophosphorylation, which then phosphorylates the alpha subunit of eIF2 (eIF2α) to inhibit translation initiation.","method":"In vitro kinase assays, cell-based assays with dsRNA activation","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro kinase activity, replicated across many independent studies over decades","pmids":["10557102"],"is_preprint":false},{"year":1999,"finding":"HCV envelope protein E2 contains a sequence identical to phosphorylation sites of PKR and eIF2α, and directly inhibits PKR kinase activity, blocking its inhibitory effect on protein synthesis and cell growth.","method":"In vitro kinase assay, cell-based protein synthesis and growth inhibition assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro kinase inhibition assay plus cell-based functional validation in a single rigorous study","pmids":["10390359"],"is_preprint":false},{"year":2008,"finding":"PKR activation by dsRNA requires dimerization: a minimal dsRNA of 30 bp is required to bind two PKR monomers and elicit autophosphorylation; PKR monomers sequentially attach to a single dsRNA and dimerize via kinase domain contacts.","method":"Sedimentation velocity analytical ultracentrifugation, autophosphorylation assays with dsRNAs of defined length","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biophysical reconstitution with defined substrates plus functional autophosphorylation assays in a single rigorous study","pmids":["18599071"],"is_preprint":false},{"year":2006,"finding":"PKR activation by dsRNA or the cellular protein PACT involves an intramolecular interaction between a PACT-binding motif (PBM) in the kinase domain and the dsRNA-binding domain that keeps PKR inactive; disruption of this interaction by point mutations produces constitutively active PKR.","method":"Biochemical assays, NMR analyses, point mutagenesis, genetic complementation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structural mapping combined with mutagenesis and functional kinase assays in a single study","pmids":["16785445"],"is_preprint":false},{"year":2005,"finding":"Crystal structures of eIF2α bound to PKR reveal that PKR forms a back-to-back parallel dimer essential for kinase activation, and demonstrate how eIF2α docks to its kinase; activation-loop phosphorylation allosterically couples dimerization and substrate recognition interfaces.","method":"X-ray crystallography, mutagenesis analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional mutagenesis validation, complemented by two independent papers (Dar et al. and Dey et al.)","pmids":["16179248"],"is_preprint":false},{"year":2013,"finding":"PKR activation requires dimerization-induced cis-phosphorylation at Thr-446 in the activation loop; dimerization precedes and stimulates activation loop autophosphorylation, and these two processes are mutually exclusive yet interdependent.","method":"Yeast Saccharomyces cerevisiae model system, PKR bypass mutants, mutagenesis of dimerization-essential residues (Asp-266, Tyr-323), eIF2α phosphorylation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis with reconstituted functional assays, multiple orthogonal genetic and biochemical approaches","pmids":["24338483"],"is_preprint":false},{"year":2009,"finding":"RNA dimerization promotes PKR dimerization and activation: TAR RNA dimers (effectively doubling dsRNA length from 23 bp to ~46 bp) bind two or three PKR molecules and activate PKR, whereas TAR monomers bind only one PKR monomer and do not activate it.","method":"Native gel electrophoresis, analytical ultracentrifugation, autophosphorylation assays, enzymatic structure mapping","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biophysical and biochemical reconstitution with multiple orthogonal methods in a single study","pmids":["19445956"],"is_preprint":false},{"year":2011,"finding":"Heparin activates PKR by binding to the kinase domain (not the dsRNA-binding domain) and allosterically enhancing PKR dimerization, demonstrating that PKR can be activated by non-RNA molecules via the kinase domain.","method":"Analytical ultracentrifugation, autophosphorylation assays, thermodynamic linkage modeling","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biophysical reconstitution with multiple orthogonal methods establishing mechanism in a single rigorous study","pmids":["21978664"],"is_preprint":false},{"year":2015,"finding":"Activating dsRNAs induce a back-to-back parallel PKR kinase dimer required for activation, whereas non-activating RNAs (e.g., containing a 2'-O-methyl barrier) either fail to induce dimerization or produce an alternative inactive dimer configuration.","method":"homo-FRET assay for kinase domain dimerization, autophosphorylation assays, mutagenesis of dimer interface residues","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — novel FRET dimerization assay combined with mutagenesis and functional assays, multiple orthogonal approaches","pmids":["26488609"],"is_preprint":false},{"year":2006,"finding":"Viral inhibitor RNAs EBER(I) (Epstein-Barr virus) and VA(I) (adenovirus) bind PKR dsRNA-binding domains using similar surfaces as activating RNAs but inhibit PKR activation; regions beyond the stem-loop dsRBD contacts are required for inhibition, demonstrating that dsRNA binding and kinase inactivation are non-equivalent.","method":"Isothermal titration calorimetry, gel electrophoresis binding assays, NMR chemical shift perturbation, autophosphorylation assays","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structural mapping combined with biophysical binding measurements and functional kinase assays","pmids":["16580685"],"is_preprint":false},{"year":2012,"finding":"PKR physically interacts with inflammasome components NLRP3, NLRP1, NLRC4, AIM2, and ASC; PKR autophosphorylation in a cell-free reconstituted system with recombinant NLRP3, ASC, and pro-caspase-1 reconstitutes inflammasome activity, and PKR deficiency severely impairs inflammasome activation and IL-1β/IL-18/HMGB1 secretion.","method":"Co-immunoprecipitation, cell-free reconstitution with recombinant proteins, genetic deletion, pharmacological inhibition, in vivo peritonitis model","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — cell-free reconstitution plus reciprocal Co-IP plus genetic KO with defined cytokine readouts, multiple orthogonal approaches","pmids":["22801494"],"is_preprint":false},{"year":2004,"finding":"PKR is a critical mediator of macrophage apoptosis downstream of TLR4; TLR4-activated PKR promotes apoptosis through inhibition of protein synthesis and activation of interferon response factor 3 (IRF3).","method":"Genetic deletion of PKR, epistasis analysis, macrophage apoptosis assays with bacterial pathogens","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined apoptotic phenotype, pathway placement via epistasis, replicated with multiple bacterial pathogens","pmids":["15029200"],"is_preprint":false},{"year":2014,"finding":"During mitosis, PKR is activated in uninfected cells by binding to dsRNAs formed by inverted Alu repeats (IRAlus) when nuclear structure is disrupted; activated PKR phosphorylates eIF2α to suppress global translation, acts as upstream kinase for JNK, and regulates levels of mitotic factors (cyclins A/B, Polo-like kinase 1) and histone H3 phosphorylation.","method":"RNAi knockdown, dominant-negative PKR expression, immunofluorescence, Western blot, cell cycle analysis, RNA pulldown","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined mitotic phenotypes, RNA-protein interaction mapping, multiple orthogonal approaches in a single study","pmids":["24939934"],"is_preprint":false},{"year":2018,"finding":"PKR interacts with endogenous mitochondrial dsRNAs (mt-dsRNAs) formed by bidirectional transcription of the mitochondrial genome; these mt-dsRNAs regulate PKR and eIF2α phosphorylation to control cell signaling and translation; PKR phosphatases counteract mt-dsRNA-driven PKR activation.","method":"Formaldehyde-mediated crosslinking and immunoprecipitation sequencing (fCLIP-seq), Western blot, genetic manipulation","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct RNA-protein crosslinking-IP sequencing combined with functional phosphorylation assays, multiple orthogonal methods","pmids":["30174290"],"is_preprint":false},{"year":2018,"finding":"Loss of PRKRA (by mis-splicing caused by TIA1/TIAL1 double knockout) triggers EIF2AK2/PKR activation and stress granule formation; ectopic expression of PRKRA cDNA or knockout of EIF2AK2 in double-knockout cells rescues this phenotype, placing PRKRA as a direct upstream regulator of PKR.","method":"Double knockout cell lines, PAR-CLIP, Western blot, genetic rescue experiments","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with double KO and rescue experiments, multiple orthogonal approaches","pmids":["29429924"],"is_preprint":false},{"year":2012,"finding":"Cytoplasmic STAT3 directly interacts with EIF2AK2/PKR via the catalytic domain of PKR and the SH2 domain of STAT3 (recapitulated with recombinant proteins in pull-down); STAT3 acts as a competitive inhibitor of PKR-mediated eIF2α phosphorylation; disruption of this complex by STAT3 inhibitors or fatty acids (palmitate) activates PKR-dependent autophagy.","method":"Recombinant protein pull-down, Co-IP, overexpression of STAT3 mutants, chemical screen, autophagy flux assays","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted pull-down with recombinant proteins plus domain-mapping mutants plus functional autophagy assays","pmids":["23221979"],"is_preprint":false},{"year":2023,"finding":"ADAR1 dsRBD3 directly interacts with PKR kinase domain on dsRNA to inhibit PKR activation; wild-type or editing-inactive ADAR1 expressed in A549 cells inhibits endogenous PKR, and mutating the ADAR1 dsRBD3-PKR contact prevents co-immunoprecipitation, ADAR1 inhibition of PKR activity, and their co-localization.","method":"Co-immunoprecipitation, AlphaFold structural modeling, functional PKR activation assays, mutagenesis of interaction interface, immunofluorescence co-localization","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with mutagenesis validation plus functional kinase assays, multiple orthogonal methods in a single study","pmids":["39146181"],"is_preprint":false},{"year":2023,"finding":"ADAR1p150 isoform prevents PKR activation through its dsRNA-binding activity (distinct from its RNA-editing function); deleting both MDA5 and PKR completely rescues embryonic lethality of Adar1p150-/- mice, whereas deleting either alone provides limited or no rescue.","method":"Genetic epistasis in mice (Adar1p150-/- × Mavs-/- × Eif2ak2-/- triple mutants), survival analysis, genetic rescue experiments","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous in vivo genetic epistasis with triple-mutant rescue, clearly distinguishes MDA5 vs PKR activation mechanisms","pmids":["37797622"],"is_preprint":false},{"year":2019,"finding":"Endogenous circRNAs act as PKR inhibitors by forming 16-26 bp imperfect RNA duplexes that suppress PKR activation; upon viral infection or poly(I:C) stimulation, RNase L degrades circRNAs, which is required for PKR activation in early innate immune responses.","method":"CircRNA overexpression/depletion, RNase L functional assays, PKR phosphorylation assays, viral infection experiments","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional reconstitution with circRNA manipulation combined with multiple orthogonal cellular assays","pmids":["31031002"],"is_preprint":false},{"year":2010,"finding":"mRNAs containing uridine activate PKR which phosphorylates eIF2α and inhibits translation; mRNAs with pseudouridine substitutions activate PKR to a lesser degree, bind PKR less efficiently (by RNA pull-down), and are translated equally in PKR knockout cells.","method":"RNA pull-down assay, PKR phosphorylation assay, PKR knockout cell translation assay","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — RNA-protein binding assay plus functional translation assay in PKR-KO cells, multiple orthogonal approaches","pmids":["20457754"],"is_preprint":false},{"year":2000,"finding":"Vaccinia virus K3L protein acts as a pseudosubstrate inhibitor of PKR; the K3L protein co-immunoprecipitates with PKR in vaccinia virus-infected cells, and its inhibitory function depends critically on residues near its C-terminus that share a sequence motif with eIF2α.","method":"Co-immunoprecipitation in infected cells, yeast growth inhibition assay, cell-free translation assay, mutagenesis","journal":"Virology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus yeast genetic assay plus cell-free functional assay, multiple orthogonal approaches","pmids":["11040133"],"is_preprint":false},{"year":2008,"finding":"Positive selection of specific residues near the eIF2α-binding site on the C-terminal lobe of PKR kinase domain governs sensitivity to poxviral pseudosubstrate inhibitors; substitution of positively selected residues altered species-specific sensitivity to K3L and related poxviral inhibitors without impairing eIF2α phosphorylation.","method":"Evolutionary analysis, site-directed mutagenesis, yeast-based PKR function assay, in vitro kinase assay","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with functional kinase assays and yeast genetic system in a single rigorous study","pmids":["19043413"],"is_preprint":false},{"year":2008,"finding":"Mutations in the C-terminal lobe of the PKR kinase domain confer resistance to vaccinia K3L pseudosubstrate inhibitor (e.g., PKR-D486V shows ~15-fold decreased K3L binding) while leaving eIF2α phosphorylation intact, mapping the eIF2α-binding site to an extensive face of the C-terminal lobe.","method":"Yeast-based PKR toxicity screen, in vitro kinase assay, binding affinity measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis screen plus in vitro binding and kinase assays, multiple orthogonal approaches","pmids":["18971339"],"is_preprint":false},{"year":2002,"finding":"HCV NS5A protein colocalizes with PKR and suppresses dsRNA activation of PKR during HCV RNA replication; mutations in the PKR-binding domain of NS5A relieved this blockade, resulting in IRF-1 activation and reduced HCV replication.","method":"Colocalization studies, PKR activation assays, NS5A mutagenesis, HCV replicon system, IRF-1 reporter assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct colocalization plus domain-mapping mutagenesis plus functional viral replication assays","pmids":["11904369"],"is_preprint":false},{"year":2004,"finding":"PKR acts as a molecular clock: its catalysis-independent activity activates NF-κB survival signaling to delay apoptosis, while its kinase activity (phosphorylation of eIF2α) subsequently induces cell death, temporally separating survival and death programs.","method":"Kinase-dead PKR mutants, NF-κB reporter assays, apoptosis assays, eIF2α phosphorylation measurements","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — kinase-dead mutant analysis dissecting catalytic vs. structural functions, multiple functional readouts","pmids":["14749731"],"is_preprint":false},{"year":2003,"finding":"PKR is a critical upstream mediator of the ribotoxic stress response: DON (deoxynivalenol) rapidly induces PKR autophosphorylation and eIF2α phosphorylation within 1-5 min, and PKR deficiency (via antisense expression) markedly suppresses downstream MAPK (JNK > p38 > ERK) phosphorylation and apoptosis.","method":"PKR inhibitor pretreatment, antisense PKR stable transformants, MAPK phosphorylation assays, apoptosis assays","journal":"Toxicological sciences","confidence":"High","confidence_rationale":"Tier 2 / Moderate — PKR-deficient cell line plus pharmacological inhibition with defined pathway readouts, multiple orthogonal approaches","pmids":["12773753"],"is_preprint":false},{"year":2018,"finding":"PKR directly binds and phosphorylates monomeric and filamentous α-synuclein on Ser129 in vitro; overexpression of constitutively active PKR increases Ser129 α-synuclein phosphorylation, while inhibition/knockdown of PKR reduces it in multiple cell models and primary neurons.","method":"In vitro phosphorylation assay, PKR inhibitor treatment, PKR siRNA knockdown, PKR overexpression, multiple cell models and acute brain slices","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro kinase-substrate assay plus loss- and gain-of-function in multiple independent cellular systems","pmids":["29501855"],"is_preprint":false},{"year":2022,"finding":"PKR forms cytosolic condensates (dsRNA-induced foci, dRIFs) in response to increased endogenous or exogenous dsRNA; dRIFs contain dsRNA, enrich dsRNA-binding proteins (ADAR1, Stau1, NLRP1, PACT), form before translation repression, and localize to regions where PKR activation is initiated; disruption of PKR clusters enhances eIF2α phosphorylation.","method":"Live-cell imaging, immunofluorescence, co-localization studies, eIF2α phosphorylation assays, dsRNA length-dependence experiments","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization with functional consequence (cluster disruption enhances phosphorylation), single lab with multiple orthogonal imaging and biochemical approaches","pmids":["35939694"],"is_preprint":false},{"year":2022,"finding":"PKR signaling involves assembly of dynamic PKR clusters driven by ligand binding and front-to-front interfaces between kinase domains; eIF2α is not recruited to PKR clusters, and PKR cluster disruption enhances eIF2α phosphorylation, suggesting clusters buffer downstream signaling.","method":"Live-cell fluorescence microscopy, genetic manipulation, eIF2α phosphorylation assays","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct imaging of PKR dynamics with functional consequence measured, single lab","pmids":["35522180"],"is_preprint":false},{"year":2016,"finding":"PKR kinase activity represses (not activates) cryopyrin/NLRP3 inflammasome activity by inhibiting protein translation of inflammasome constituents to prevent initial priming during innate immune signaling, as demonstrated by a knock-in mouse expressing kinase-dead PKR.","method":"Kinase-dead knock-in mouse, PKR-null mouse, inflammasome activation assays, translation inhibition measurements","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent transgenic mouse models (kinase-dead knock-in and null), with defined mechanistic pathway (translation inhibition of inflammasome components), directly contradicts earlier reports","pmids":["26794869"],"is_preprint":false},{"year":2013,"finding":"PKR is activated by CD40 ligation via TRAF6 and TRAF2: TRAF6 co-immunoprecipitates with PKR upon CD40 ligation, TRAF2 bridges TRAF6 and PKR, and PKR activation promotes autophagy and LC3 accumulation around Toxoplasma gondii vacuoles for parasite killing.","method":"Co-immunoprecipitation, TRAF2-deficient cells, PKR-null mice, autophagy assays, vacuole-lysosomal fusion assays, parasite killing assays","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with defined pathway components plus functional KO phenotype, multiple orthogonal methods","pmids":["23990781"],"is_preprint":false},{"year":2019,"finding":"PKR promotes G3BP1 foci formation via an RNA-dependent association, which is necessary for cGAS condensation and cGAS-dependent interferon responses to intracellular DNA.","method":"Co-immunoprecipitation, loss-of-function (G3BP1 and PKR knockdown), interferon response assays, immunofluorescence","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional knockdown with defined innate immune readout plus Co-IP, single lab","pmids":["31772125"],"is_preprint":false},{"year":2020,"finding":"RAN translation from structured CAG, CCUG, CAGG, and G4C2 expansion RNAs is regulated by PKR; blocking PKR via dominant-negative PKR-K296R, TRBP overexpression, or PKR-KO reduces RAN protein levels; inhibiting PKR in C9orf72 BAC transgenic mice with AAV-PKR-K296R or metformin decreases RAN proteins and improves behavior.","method":"PKR-KO cells, dominant-negative PKR expression, PKR inhibitors, in vivo AAV delivery, C9orf72 BAC transgenic mouse model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent loss-of-function approaches (KO, dominant-negative, pharmacological) plus in vivo animal model validation","pmids":["32690681"],"is_preprint":false},{"year":2022,"finding":"EIF2AK2/PKR bridges YTHDF3 and eIF3A, enhancing the stability of the YTHDF3/eIF3A complex in oxaliplatin-resistant colorectal cancer cells to facilitate translation of m6A-methylated mRNAs.","method":"Co-immunoprecipitation, Western blot, functional translation assays","journal":"ACS chemical biology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP experiment, single lab, no mechanistic mutagenesis or reconstitution","pmids":["35708211"],"is_preprint":false},{"year":2022,"finding":"Berberine directly binds EIF2AK2 (via two ionic bonds by chemoproteomic analysis), subtly inhibits EIF2AK2 dimerization rather than its enzyme activity, and selectively modulates downstream JNK, NF-κB, AKT, and NLRP3 pathways; EIF2AK2 knockdown attenuates berberine's anti-inflammatory effects in vivo.","method":"Chemoproteomic target identification, binding affinity measurements, EIF2AK2 knockdown mice, cytokine assays, dimerization assays","journal":"Acta pharmaceutica Sinica B","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chemoproteomic target ID plus in vivo genetic validation plus dimerization assay, multiple orthogonal approaches, single lab","pmids":["37250154"],"is_preprint":false},{"year":2023,"finding":"APOBEC3B forms a complex with PABPC1 to stimulate PKR and counterbalances PKR-suppressing activity of ADAR1 during viral infection, promoting translational blockage and stress granule formation; APOBEC3B localizes to stress granules through its interaction with PABPC1.","method":"Co-immunoprecipitation, loss-of-function studies, eIF2α phosphorylation assays, stress granule imaging, viral infection experiments","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP defining complex plus multiple functional assays, single lab","pmids":["36781883"],"is_preprint":false},{"year":2024,"finding":"EIF2AK2 directly targets and positively regulates AIM2 expression; Co-IP demonstrates direct binding between EIF2AK2 and AIM2, and EIF2AK2 induces PANoptosis through upregulating AIM2 in LPS-treated renal tubular cells.","method":"Co-immunoprecipitation, Western blot, siRNA knockdown, LPS-stimulated cell model","journal":"Renal failure","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP with limited mechanistic follow-up, single lab","pmids":["39311631"],"is_preprint":false},{"year":2023,"finding":"Reduction of PNPT1 leads to leakage of mitochondrial dsRNA into cytoplasm where it activates PKR, causing eIF2α phosphorylation and translational arrest leading to renal tubular atrophy; inhibiting PKR rescues ischemia-reperfusion or ureteral obstruction-induced renal tubular injury in mice.","method":"PNPT1 knockout mice, PKR inhibitor treatment, Western blot, in vivo mouse models, histopathology","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus pharmacological inhibition plus in vivo rescue, multiple orthogonal approaches, independently replicated pathway","pmids":["36869030"],"is_preprint":false},{"year":2021,"finding":"Human DICER helicase domain directly interacts with PKR (enriched by proteomics during viral infection); deletion of the DICER helicase domain confers antiviral properties in an RNAi-independent, PKR-dependent manner.","method":"Proteomics/interactome analysis, domain-deletion mutants, viral replication assays, PKR-dependency genetic experiments","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteomics-based interaction plus genetic domain deletion with PKR-dependent functional readout, single lab","pmids":["33984068"],"is_preprint":false},{"year":2020,"finding":"EIF2AK2 missense variants (p.Gly130Arg, p.Gly138Ala, p.Asn32Thr) found in dystonia patients show abnormally enhanced PKR-mediated phosphorylation of eIF2α in patient-derived fibroblasts, demonstrating gain-of-function kinase activity.","method":"Patient-derived fibroblast studies, Western blot for eIF2α phosphorylation, Sanger sequencing","journal":"Annals of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived cell functional assays confirming gain-of-function, single lab, limited mechanistic follow-up","pmids":["33236446"],"is_preprint":false},{"year":2020,"finding":"EIF2AK2 missense variants associated with neurodevelopmental syndrome show reduced kinase activity in mammalian cell lines and proband-derived fibroblasts, linking deficient eIF2α phosphorylation to the disease phenotype.","method":"Mammalian cell line transfection, patient-derived fibroblast functional assays, Western blot for eIF2α phosphorylation","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional kinase assays in patient-derived cells, single lab, limited mechanistic depth","pmids":["32197074"],"is_preprint":false},{"year":2017,"finding":"PKR activation in TNF-α-stimulated chondrocytes triggers PKC phosphorylation, which activates NADPH oxidase leading to oxidative stress; this cascade activates COX-2 and IL-8 via ERK/NF-κB pathway and impedes PPAR-γ-mediated inhibition of MMP-13.","method":"PKR activation with poly(I:C), PKR/PKC pathway inhibitors, Western blot, NADPH oxidase activity assay, OA patient cartilage","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway dissection with multiple signaling readouts, single lab","pmids":["28869834"],"is_preprint":false},{"year":2012,"finding":"In PKR-null colonic epithelial cells during DSS colitis, eIF2α phosphorylation-mediated unfolded protein response (UPR), ER chaperone response, ERAD, and antioxidative stress response are impaired, as are STAT3 and AKT phosphorylation, demonstrating PKR's role in coordinating multiple pro-survival signaling pathways in epithelial cells.","method":"PKR-null mice with bone marrow reconstitution, DSS colitis model, Western blot for pathway components","journal":"Inflammatory bowel diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic KO with defined cellular phenotype and multiple biochemical readouts, single lab","pmids":["22275310"],"is_preprint":false},{"year":1993,"finding":"The PRKR (EIF2AK2) gene was mapped to human chromosome 2p21-p22 and mouse chromosome 17 E2 using somatic cell hybrids and fluorescence in situ hybridization.","method":"Somatic cell hybrid panel, fluorescence in situ hybridization (FISH)","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 / Strong — independent chromosomal mapping by two groups using orthogonal methods (FISH and somatic cell hybrids), replicated","pmids":["7686883","7686884"],"is_preprint":false}],"current_model":"EIF2AK2/PKR is an interferon-inducible serine/threonine kinase that senses dsRNA (viral or endogenous, including mitochondrial dsRNA and inverted-Alu repeat-containing RNAs) via its N-terminal dsRNA-binding domain; dsRNA binding drives back-to-back kinase-domain dimerization and cis-autophosphorylation at Thr-446 in the activation loop, activating PKR to phosphorylate eIF2α on Ser-51, thereby globally inhibiting translation initiation; activated PKR also directly phosphorylates α-synuclein on Ser-129, interacts with inflammasome components (NLRP3, NLRP1, NLRC4, AIM2, ASC) to regulate inflammasome assembly, activates NF-κB in a kinase-independent manner, acts upstream of JNK/p38/ERK MAPKs, promotes apoptosis via IRF3 and FADD/caspase-8, and is regulated by multiple binding partners (PACT activates; TRBP, ADAR1, STAT3, nc886, and circRNAs inhibit) as well as by dynamic cytosolic condensate formation."},"narrative":{"mechanistic_narrative":"EIF2AK2/PKR is a dsRNA-activated serine/threonine kinase that couples detection of double-stranded RNA to global translational control and innate immune signaling [PMID:10557102]. Activation is conformational and dimerization-dependent: an inhibitory intramolecular contact between a kinase-domain motif and the dsRNA-binding domain keeps PKR latent, and dsRNA binding relieves this autoinhibition by recruiting two monomers onto a single duplex (minimally ~30 bp) to drive back-to-back kinase-domain dimerization [PMID:18599071, PMID:16785445, PMID:16179248]. Dimerization triggers cis-autophosphorylation at Thr-446 in the activation loop, allosterically coupling the dimerization and substrate interfaces so that activated PKR phosphorylates eIF2α to block translation initiation [PMID:16179248, PMID:24338483]. The duplex length and structure of the activating RNA dictate productive dimer geometry, and PKR can also be activated through its kinase domain by non-RNA ligands such as heparin, indicating that dimerization—not nucleic-acid binding per se—is the activating event [PMID:19445956, PMID:21978664, PMID:26488609]. Beyond viral dsRNA, PKR senses endogenous ligands including inverted-Alu repeat RNAs exposed during mitosis and mitochondrial dsRNA released upon loss of mitochondrial RNA turnover, linking it to cell-cycle translational suppression and to renal tubular injury [PMID:24939934, PMID:30174290, PMID:36869030]. PKR also functions as a substrate kinase beyond eIF2α, directly phosphorylating α-synuclein on Ser-129 [PMID:29501855]. Functionally, PKR is an apoptotic and inflammatory effector: it mediates macrophage death downstream of TLR4 via IRF3 [PMID:15029200], drives ribotoxic-stress MAPK signaling (JNK/p38/ERK) and apoptosis [PMID:12773753], and acts as a temporal switch using kinase-independent NF-κB survival signaling versus kinase-dependent eIF2α-mediated death [PMID:14749731]. Its activity is tightly set by competing regulators—PACT/PRKRA and APOBEC3B-PABPC1 promote activation, while STAT3, ADAR1, and endogenous circRNAs inhibit it—and viral antagonists (HCV E2 and NS5A, vaccinia K3L pseudosubstrate, EBER/VA-I RNAs) suppress PKR to evade the antiviral response [PMID:10390359, PMID:16785445, PMID:16580685, PMID:29429924, PMID:23221979, PMID:39146181, PMID:31031002, PMID:11040133, PMID:11904369, PMID:36781883]. Spatially, dsRNA induces cytosolic PKR condensates that organize and buffer downstream eIF2α phosphorylation [PMID:35939694, PMID:35522180]. Bidirectional EIF2AK2 missense variants cause neurological disease: gain-of-function alleles with enhanced eIF2α phosphorylation underlie dystonia, while loss-of-function alleles cause a neurodevelopmental syndrome [PMID:33236446, PMID:32197074].","teleology":[{"year":1993,"claim":"Establishing the human and mouse chromosomal location of EIF2AK2 provided the genomic anchor for subsequent functional and genetic study.","evidence":"Somatic cell hybrid panels and FISH mapping to human 2p21-p22 and mouse chromosome 17 E2","pmids":["7686883","7686884"],"confidence":"High","gaps":["Mapping alone established no function","No gene structure or regulatory elements defined"]},{"year":1999,"claim":"Defining the core enzymatic logic—dsRNA binding triggers autophosphorylation, which enables eIF2α phosphorylation and translational shutdown—answered what PKR does at the molecular level.","evidence":"In vitro kinase assays and dsRNA-activated cell-based assays","pmids":["10557102"],"confidence":"High","gaps":["Structural basis of dsRNA-driven activation not resolved","Stoichiometry of activation undefined at this stage"]},{"year":2005,"claim":"Crystal structures of the PKR–eIF2α complex revealed back-to-back parallel dimerization as the activation mechanism and showed how substrate docks, settling how activation and substrate recognition are coupled.","evidence":"X-ray crystallography with mutagenesis validation","pmids":["16179248"],"confidence":"High","gaps":["Did not show how dsRNA length controls dimer geometry","Did not resolve the autoinhibited latent state"]},{"year":2008,"claim":"Biophysical reconstitution established that dimerization is the activating event—a minimal ~30 bp duplex binds two monomers—distinguishing RNA binding from kinase activation.","evidence":"Analytical ultracentrifugation and length-defined autophosphorylation assays; complemented by RNA-dimerization and pseudosubstrate residue studies","pmids":["18599071","19445956","18971339","19043413"],"confidence":"High","gaps":["In-cell relevance of minimal duplex thresholds untested at the time","Did not address non-RNA activators"]},{"year":2006,"claim":"Identifying an intramolecular autoinhibitory contact between the kinase domain and dsRNA-binding domain explained how PKR is held latent and how PACT and dsRNA relieve inhibition.","evidence":"NMR mapping, point mutagenesis yielding constitutively active PKR, genetic complementation; inhibitory RNAs (EBER/VA-I) shown to bind but not activate","pmids":["16785445","16580685"],"confidence":"High","gaps":["Quantitative contribution of autoinhibition to basal control unclear","How specific ligands tip the equilibrium not fully resolved"]},{"year":2013,"claim":"Demonstrating that dimerization drives cis-autophosphorylation specifically at Thr-446 ordered the activation steps mechanistically.","evidence":"Yeast genetic system with bypass and dimerization-interface mutants and eIF2α phosphorylation readouts; FRET dimerization assay distinguishing activating vs non-activating RNAs (2015)","pmids":["24338483","26488609","21978664"],"confidence":"High","gaps":["Kinetics of dimer-to-phosphorylation transition in cells incompletely defined","Alternative inactive dimer states only partially characterized"]},{"year":2004,"claim":"Separating kinase-independent NF-κB survival signaling from kinase-dependent eIF2α-mediated death established PKR as a temporal apoptotic switch and a node beyond translation control.","evidence":"Kinase-dead mutants with NF-κB reporter and apoptosis assays; TLR4-IRF3 apoptosis epistasis in macrophages","pmids":["14749731","15029200"],"confidence":"High","gaps":["Direct NF-κB activation mechanism not molecularly defined","How the same kinase routes to survival vs death contextually unresolved"]},{"year":2003,"claim":"Placing PKR upstream of the MAPK ribotoxic stress response connected dsRNA-independent stress to JNK/p38/ERK and apoptosis.","evidence":"PKR-deficient (antisense) cells and inhibitor pretreatment with MAPK and apoptosis readouts; chondrocyte PKC/NADPH-oxidase cascade","pmids":["12773753","28869834"],"confidence":"High","gaps":["Direct PKR substrates linking to MAPK activation not identified","Distinction from eIF2α-dependent effects incomplete"]},{"year":2012,"claim":"Linking PKR physically and functionally to inflammasome assembly extended its role into innate cytokine output, though the directionality of this control was later contested.","evidence":"Co-IP with NLRP3/NLRP1/NLRC4/AIM2/ASC, cell-free reconstitution, and KO with cytokine readouts (2012) versus kinase-dead/null knock-in mice showing kinase activity represses NLRP3 (2016)","pmids":["22801494","26794869"],"confidence":"High","gaps":["The 2012 promoting role and 2016 repressing role are not reconciled","Context-dependence (priming vs assembly) not fully delineated"]},{"year":2012,"claim":"Identifying competing protein regulators (STAT3, PACT/PRKRA, ADAR1, APOBEC3B-PABPC1) defined how PKR's activation threshold is tuned in the absence of pathogen.","evidence":"Recombinant pull-downs, domain-mapping, Co-IP with mutagenesis, genetic rescue/epistasis, and in vivo triple-mutant mouse rescue","pmids":["23221979","29429924","16785445","39146181","37797622","36781883"],"confidence":"High","gaps":["Hierarchy and competition among regulators in vivo not quantified","Cell-type-specific dominance of inhibitors vs activators unresolved"]},{"year":2014,"claim":"Showing that endogenous dsRNAs (inverted-Alu repeats during mitosis, mitochondrial dsRNA) activate PKR established a self-RNA sensing role with cell-cycle and tissue-injury consequences.","evidence":"RNAi/dominant-negative with cell-cycle readouts; fCLIP-seq of mt-dsRNA; PNPT1-KO and PKR-inhibitor renal injury rescue in mice","pmids":["24939934","30174290","36869030"],"confidence":"High","gaps":["Triggers gating self-RNA exposure not fully mapped","Phosphatase counter-regulation of mt-dsRNA-driven PKR only partly characterized"]},{"year":2018,"claim":"Identifying α-synuclein Ser-129 as a direct PKR substrate expanded the kinase's substrate repertoire beyond eIF2α into neurodegeneration-relevant biology.","evidence":"In vitro kinase-substrate assay plus loss- and gain-of-function across multiple cell models and brain slices","pmids":["29501855"],"confidence":"High","gaps":["In vivo contribution to synucleinopathy not established here","Whether activation route differs from canonical dsRNA sensing unclear"]},{"year":2019,"claim":"Discovering ligand-driven PKR cytosolic condensates (dRIFs/clusters) added a spatial layer in which clustering organizes activation yet buffers downstream eIF2α phosphorylation.","evidence":"Live-cell imaging, co-localization, and cluster-disruption phosphorylation assays; G3BP1/cGAS condensation coupling","pmids":["35939694","35522180","31772125"],"confidence":"Medium","gaps":["Single-lab imaging-based mechanism awaits orthogonal validation","Molecular determinants of condensate assembly and dissolution undefined"]},{"year":2020,"claim":"Bidirectional EIF2AK2 disease variants demonstrated that both excess and deficient kinase activity are pathogenic, linking eIF2α-phosphorylation dosage to human neurological disease.","evidence":"Patient-derived fibroblast and transfection eIF2α-phosphorylation assays for gain-of-function (dystonia) and loss-of-function (neurodevelopmental syndrome) variants","pmids":["33236446","32197074"],"confidence":"Medium","gaps":["Mechanism connecting altered kinase output to specific phenotypes unresolved","Single-lab functional characterization with limited mechanistic depth"]},{"year":null,"claim":"How PKR discriminates self from non-self dsRNA in vivo, and how condensate dynamics, competing regulators, and contradictory inflammasome roles are integrated into a unified activation set-point, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No quantitative model reconciling promoting vs repressing inflammasome roles","Spatial condensate control of signaling lacks structural mechanism","Self-RNA gating thresholds not defined across tissues"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,5,26]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,4,5,26]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,2,6,12,13,19]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[15,27,28]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[12]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,11,18,30]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,19]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[11,24,25]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[25,13,37]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[15,30]}],"complexes":["NLRP3 inflammasome"],"partners":["EIF2S1","PRKRA","STAT3","ADAR1","NLRP3","ASC","TRAF6","G3BP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P19525","full_name":"Interferon-induced, double-stranded RNA-activated protein kinase","aliases":["Eukaryotic translation initiation factor 2-alpha kinase 2","eIF-2A protein kinase 2","Interferon-inducible RNA-dependent protein kinase","P1/eIF-2A protein kinase","Protein kinase RNA-activated","PKR","Protein kinase R","Tyrosine-protein kinase EIF2AK2","p68 kinase"],"length_aa":551,"mass_kda":62.1,"function":"IFN-induced dsRNA-dependent serine/threonine-protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) and plays a key role in the innate immune response to viral infection (PubMed:18835251, PubMed:19189853, PubMed:19507191, PubMed:21072047, PubMed:21123651, PubMed:22381929, PubMed:22948139, PubMed:23229543). Inhibits viral replication via the integrated stress response (ISR): EIF2S1/eIF-2-alpha phosphorylation in response to viral infection converts EIF2S1/eIF-2-alpha in a global protein synthesis inhibitor, resulting to a shutdown of cellular and viral protein synthesis, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activator ATF4 (PubMed:19189853, PubMed:21123651, PubMed:22948139, PubMed:23229543). Exerts its antiviral activity on a wide range of DNA and RNA viruses including hepatitis C virus (HCV), hepatitis B virus (HBV), measles virus (MV) and herpes simplex virus 1 (HHV-1) (PubMed:11836380, PubMed:19189853, PubMed:19840259, PubMed:20171114, PubMed:21710204, PubMed:23115276, PubMed:23399035). Also involved in the regulation of signal transduction, apoptosis, cell proliferation and differentiation: phosphorylates other substrates including p53/TP53, PPP2R5A, DHX9, ILF3, IRS1 and the HHV-1 viral protein US11 (PubMed:11836380, PubMed:19229320, PubMed:22214662). In addition to serine/threonine-protein kinase activity, also has tyrosine-protein kinase activity and phosphorylates CDK1 at 'Tyr-4' upon DNA damage, facilitating its ubiquitination and proteasomal degradation (PubMed:20395957). Either as an adapter protein and/or via its kinase activity, can regulate various signaling pathways (p38 MAP kinase, NF-kappa-B and insulin signaling pathways) and transcription factors (JUN, STAT1, STAT3, IRF1, ATF3) involved in the expression of genes encoding pro-inflammatory cytokines and IFNs (PubMed:22948139, PubMed:23084476, PubMed:23372823). Activates the NF-kappa-B pathway via interaction with IKBKB and TRAF family of proteins and activates the p38 MAP kinase pathway via interaction with MAP2K6 (PubMed:10848580, PubMed:15121867, PubMed:15229216). Can act as both a positive and negative regulator of the insulin signaling pathway (ISP) (PubMed:20685959). Negatively regulates ISP by inducing the inhibitory phosphorylation of insulin receptor substrate 1 (IRS1) at 'Ser-312' and positively regulates ISP via phosphorylation of PPP2R5A which activates FOXO1, which in turn up-regulates the expression of insulin receptor substrate 2 (IRS2) (PubMed:20685959). Can regulate NLRP3 inflammasome assembly and the activation of NLRP3, NLRP1, AIM2 and NLRC4 inflammasomes (PubMed:22801494). Plays a role in the regulation of the cytoskeleton by binding to gelsolin (GSN), sequestering the protein in an inactive conformation away from actin (By similarity)","subcellular_location":"Cytoplasm; Nucleus; Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/P19525/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/EIF2AK2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000055332","cell_line_id":"CID000738","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleolus_gc","grade":1}],"interactors":[{"gene":"DHX9","stoichiometry":0.2},{"gene":"ZNF346","stoichiometry":0.2},{"gene":"STAU1","stoichiometry":0.2},{"gene":"CKAP4","stoichiometry":0.2},{"gene":"FBXO32","stoichiometry":0.2},{"gene":"ZC3H11A","stoichiometry":0.2},{"gene":"ADAR","stoichiometry":0.2},{"gene":"ILF3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000738","total_profiled":1310},"omim":[{"mim_id":"619687","title":"DYSTONIA 33; DYT33","url":"https://www.omim.org/entry/619687"},{"mim_id":"618878","title":"LEUKOENCEPHALOPATHY, MOTOR DELAY, SPASTICITY, AND DYSARTHRIA SYNDROME; LEMSPAD","url":"https://www.omim.org/entry/618878"},{"mim_id":"618877","title":"LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME; LEUDEN","url":"https://www.omim.org/entry/618877"},{"mim_id":"617458","title":"PRKR-INTERACTING PROTEIN 1, IL11-INDUCIBLE; PRKRIP1","url":"https://www.omim.org/entry/617458"},{"mim_id":"616097","title":"UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 3; UQCC3","url":"https://www.omim.org/entry/616097"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/EIF2AK2"},"hgnc":{"alias_symbol":["PKR","PPP1R83"],"prev_symbol":["PRKR"]},"alphafold":{"accession":"P19525","domains":[{"cath_id":"3.30.160.20","chopping":"10-78","consensus_level":"high","plddt":84.6616,"start":10,"end":78},{"cath_id":"3.30.160.20","chopping":"102-169","consensus_level":"high","plddt":80.5637,"start":102,"end":169},{"cath_id":"3.30.200.20","chopping":"262-338_358-368","consensus_level":"high","plddt":91.1343,"start":262,"end":368},{"cath_id":"1.10.510.10","chopping":"373-542","consensus_level":"high","plddt":92.0311,"start":373,"end":542}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P19525","model_url":"https://alphafold.ebi.ac.uk/files/AF-P19525-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P19525-F1-predicted_aligned_error_v6.png","plddt_mean":76.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EIF2AK2","jax_strain_url":"https://www.jax.org/strain/search?query=EIF2AK2"},"sequence":{"accession":"P19525","fasta_url":"https://rest.uniprot.org/uniprotkb/P19525.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P19525/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P19525"}},"corpus_meta":[{"pmid":"10557102","id":"PMC_10557102","title":"PKR; a sentinel kinase for cellular stress.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10557102","citation_count":669,"is_preprint":false},{"pmid":"31031002","id":"PMC_31031002","title":"Structure and Degradation of Circular RNAs Regulate PKR Activation in Innate Immunity.","date":"2019","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/31031002","citation_count":668,"is_preprint":false},{"pmid":"17158706","id":"PMC_17158706","title":"Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.","date":"2006","source":"Microbiology and molecular biology reviews : MMBR","url":"https://pubmed.ncbi.nlm.nih.gov/17158706","citation_count":653,"is_preprint":false},{"pmid":"22801494","id":"PMC_22801494","title":"Novel role of PKR in inflammasome activation and HMGB1 release.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22801494","citation_count":640,"is_preprint":false},{"pmid":"10390359","id":"PMC_10390359","title":"Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10390359","citation_count":579,"is_preprint":false},{"pmid":"20457754","id":"PMC_20457754","title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20457754","citation_count":526,"is_preprint":false},{"pmid":"17451862","id":"PMC_17451862","title":"The dsRNA protein kinase PKR: virus and cell control.","date":"2007","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/17451862","citation_count":524,"is_preprint":false},{"pmid":"11752661","id":"PMC_11752661","title":"Signal integration via PKR.","date":"2001","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/11752661","citation_count":314,"is_preprint":false},{"pmid":"11232238","id":"PMC_11232238","title":"Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action.","date":"2000","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/11232238","citation_count":304,"is_preprint":false},{"pmid":"15029200","id":"PMC_15029200","title":"The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4.","date":"2004","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15029200","citation_count":299,"is_preprint":false},{"pmid":"30686999","id":"PMC_30686999","title":"PKR: A Kinase to Remember.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30686999","citation_count":219,"is_preprint":false},{"pmid":"7631421","id":"PMC_7631421","title":"PKR: a new name and new roles.","date":"1995","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/7631421","citation_count":207,"is_preprint":false},{"pmid":"30174290","id":"PMC_30174290","title":"PKR Senses Nuclear and Mitochondrial Signals by Interacting with Endogenous Double-Stranded RNAs.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30174290","citation_count":200,"is_preprint":false},{"pmid":"16704884","id":"PMC_16704884","title":"Inhibition of PKR by RNA and DNA viruses.","date":"2006","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/16704884","citation_count":174,"is_preprint":false},{"pmid":"18599071","id":"PMC_18599071","title":"Mechanism of PKR Activation by dsRNA.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18599071","citation_count":172,"is_preprint":false},{"pmid":"10216948","id":"PMC_10216948","title":"PKR, apoptosis and cancer.","date":"1999","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10216948","citation_count":166,"is_preprint":false},{"pmid":"9375375","id":"PMC_9375375","title":"PKR--a protein kinase regulated by double-stranded RNA.","date":"1997","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9375375","citation_count":161,"is_preprint":false},{"pmid":"36038948","id":"PMC_36038948","title":"CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.","date":"2022","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36038948","citation_count":157,"is_preprint":false},{"pmid":"11904369","id":"PMC_11904369","title":"Regulation of PKR and IRF-1 during hepatitis C virus RNA replication.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11904369","citation_count":139,"is_preprint":false},{"pmid":"34951963","id":"PMC_34951963","title":"RNA circles with minimized immunogenicity as potent PKR inhibitors.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/34951963","citation_count":136,"is_preprint":false},{"pmid":"12773753","id":"PMC_12773753","title":"Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response.","date":"2003","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/12773753","citation_count":133,"is_preprint":false},{"pmid":"17196820","id":"PMC_17196820","title":"Activation of PKR: an open and shut case?","date":"2006","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17196820","citation_count":124,"is_preprint":false},{"pmid":"24939934","id":"PMC_24939934","title":"PKR is activated by cellular dsRNAs during mitosis and acts as a mitotic regulator.","date":"2014","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/24939934","citation_count":122,"is_preprint":false},{"pmid":"21145228","id":"PMC_21145228","title":"Regulation of innate immunity through RNA structure and the protein kinase PKR.","date":"2010","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/21145228","citation_count":114,"is_preprint":false},{"pmid":"32690681","id":"PMC_32690681","title":"Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32690681","citation_count":113,"is_preprint":false},{"pmid":"16179248","id":"PMC_16179248","title":"PKR and eIF2alpha: integration of kinase dimerization, activation, and substrate docking.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16179248","citation_count":111,"is_preprint":false},{"pmid":"16785445","id":"PMC_16785445","title":"Molecular basis for PKR activation by PACT or dsRNA.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16785445","citation_count":110,"is_preprint":false},{"pmid":"19043413","id":"PMC_19043413","title":"Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors.","date":"2008","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19043413","citation_count":107,"is_preprint":false},{"pmid":"21994559","id":"PMC_21994559","title":"Activation of the Antiviral Kinase PKR and Viral Countermeasures.","date":"2009","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/21994559","citation_count":100,"is_preprint":false},{"pmid":"29429924","id":"PMC_29429924","title":"The TIA1 RNA-Binding Protein Family Regulates EIF2AK2-Mediated Stress Response and Cell Cycle Progression.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29429924","citation_count":96,"is_preprint":false},{"pmid":"14749731","id":"PMC_14749731","title":"The protein kinase PKR: a molecular clock that sequentially activates survival and death programs.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14749731","citation_count":91,"is_preprint":false},{"pmid":"23092889","id":"PMC_23092889","title":"PKR-dependent inflammatory signals.","date":"2012","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/23092889","citation_count":85,"is_preprint":false},{"pmid":"24522206","id":"PMC_24522206","title":"The impact of PKR activation: from neurodegeneration to cancer.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24522206","citation_count":85,"is_preprint":false},{"pmid":"37797622","id":"PMC_37797622","title":"ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/37797622","citation_count":83,"is_preprint":false},{"pmid":"9150867","id":"PMC_9150867","title":"The regulation of the protein kinase PKR by RNA.","date":"1996","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/9150867","citation_count":81,"is_preprint":false},{"pmid":"18418049","id":"PMC_18418049","title":"PERK and PKR: old kinases learn new tricks.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18418049","citation_count":78,"is_preprint":false},{"pmid":"34759908","id":"PMC_34759908","title":"Inhibition of PKR by Viruses.","date":"2021","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34759908","citation_count":77,"is_preprint":false},{"pmid":"21636578","id":"PMC_21636578","title":"Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21636578","citation_count":72,"is_preprint":false},{"pmid":"19445956","id":"PMC_19445956","title":"RNA dimerization promotes PKR dimerization and activation.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19445956","citation_count":70,"is_preprint":false},{"pmid":"37250154","id":"PMC_37250154","title":"Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects.","date":"2022","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/37250154","citation_count":67,"is_preprint":false},{"pmid":"9114594","id":"PMC_9114594","title":"The PKR protein kinase--an interferon-inducible regulator of cell growth and differentiation.","date":"1997","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/9114594","citation_count":66,"is_preprint":false},{"pmid":"28982375","id":"PMC_28982375","title":"PKR involvement in Alzheimer's disease.","date":"2017","source":"Alzheimer's research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/28982375","citation_count":64,"is_preprint":false},{"pmid":"21294215","id":"PMC_21294215","title":"Multiple levels of PKR inhibition during HIV-1 replication.","date":"2010","source":"Reviews in medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/21294215","citation_count":64,"is_preprint":false},{"pmid":"14989595","id":"PMC_14989595","title":"PKR activation in neurodegenerative disease.","date":"2004","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/14989595","citation_count":63,"is_preprint":false},{"pmid":"32197074","id":"PMC_32197074","title":"De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.","date":"2020","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32197074","citation_count":59,"is_preprint":false},{"pmid":"7893827","id":"PMC_7893827","title":"Proteins that interact with PKR.","date":"1994","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/7893827","citation_count":57,"is_preprint":false},{"pmid":"33387379","id":"PMC_33387379","title":"A tale of two proteins: PACT and PKR and their roles in inflammation.","date":"2021","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/33387379","citation_count":57,"is_preprint":false},{"pmid":"16580685","id":"PMC_16580685","title":"Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs.","date":"2006","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16580685","citation_count":57,"is_preprint":false},{"pmid":"35939694","id":"PMC_35939694","title":"dsRNA-induced condensation of antiviral proteins modulates PKR activity.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35939694","citation_count":56,"is_preprint":false},{"pmid":"31772125","id":"PMC_31772125","title":"PKR-dependent cytosolic cGAS foci are necessary for intracellular DNA sensing.","date":"2019","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/31772125","citation_count":55,"is_preprint":false},{"pmid":"33236446","id":"PMC_33236446","title":"EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia.","date":"2020","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33236446","citation_count":54,"is_preprint":false},{"pmid":"23221979","id":"PMC_23221979","title":"Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy.","date":"2012","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/23221979","citation_count":52,"is_preprint":false},{"pmid":"18217692","id":"PMC_18217692","title":"PKR in innate immunity, cancer, and viral oncolysis.","date":"2007","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/18217692","citation_count":51,"is_preprint":false},{"pmid":"28869834","id":"PMC_28869834","title":"PKR activation causes inflammation and MMP-13 secretion in human degenerated articular chondrocytes.","date":"2017","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/28869834","citation_count":51,"is_preprint":false},{"pmid":"24338483","id":"PMC_24338483","title":"Activation of protein kinase PKR requires dimerization-induced cis-phosphorylation within the activation loop.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24338483","citation_count":49,"is_preprint":false},{"pmid":"36683218","id":"PMC_36683218","title":"Chemotherapy-Induced Senescence Reprogramming Promotes Nasopharyngeal Carcinoma Metastasis by circRNA-Mediated PKR Activation.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36683218","citation_count":46,"is_preprint":false},{"pmid":"17420072","id":"PMC_17420072","title":"Double stranded RNA activated EIF2 alpha kinase (EIF2AK2; PKR) is associated with Alzheimer's disease.","date":"2007","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/17420072","citation_count":43,"is_preprint":false},{"pmid":"22275310","id":"PMC_22275310","title":"PKR protects colonic epithelium against colitis through the unfolded protein response and prosurvival signaling.","date":"2012","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22275310","citation_count":43,"is_preprint":false},{"pmid":"35858300","id":"PMC_35858300","title":"Viral evasion of PKR restriction by reprogramming cellular stress granules.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35858300","citation_count":41,"is_preprint":false},{"pmid":"11120763","id":"PMC_11120763","title":"Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients.","date":"2000","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11120763","citation_count":41,"is_preprint":false},{"pmid":"7686883","id":"PMC_7686883","title":"Chromosomal assignment of the interferon-inducible double-stranded RNA-dependent protein kinase (PRKR) to human chromosome 2p21-p22 and mouse chromosome 17 E2.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7686883","citation_count":40,"is_preprint":false},{"pmid":"35522180","id":"PMC_35522180","title":"Signaling by the integrated stress response kinase PKR is fine-tuned by dynamic clustering.","date":"2022","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35522180","citation_count":39,"is_preprint":false},{"pmid":"28341446","id":"PMC_28341446","title":"PKR induces the expression of NLRP3 by regulating the NF-κB pathway in Porphyromonas gingivalis-infected osteoblasts.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28341446","citation_count":39,"is_preprint":false},{"pmid":"35708211","id":"PMC_35708211","title":"YTHDF3 Facilitates eIF2AK2 and eIF3A Recruitment on mRNAs to Regulate Translational Processes in Oxaliplatin-Resistant Colorectal Cancer.","date":"2022","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/35708211","citation_count":37,"is_preprint":false},{"pmid":"36781883","id":"PMC_36781883","title":"APOBEC3B drives PKR-mediated translation shutdown and protects stress granules in response to viral infection.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36781883","citation_count":37,"is_preprint":false},{"pmid":"11040133","id":"PMC_11040133","title":"Pseudosubstrate inhibition of protein kinase PKR by swine pox virus C8L gene product.","date":"2000","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/11040133","citation_count":37,"is_preprint":false},{"pmid":"25590804","id":"PMC_25590804","title":"PKR downregulation prevents neurodegeneration and β-amyloid production in a thiamine-deficient model.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25590804","citation_count":36,"is_preprint":false},{"pmid":"29501855","id":"PMC_29501855","title":"Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death.","date":"2018","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/29501855","citation_count":35,"is_preprint":false},{"pmid":"26052716","id":"PMC_26052716","title":"Serum Amyloid A Stimulates PKR Expression and HMGB1 Release Possibly through TLR4/RAGE Receptors.","date":"2015","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/26052716","citation_count":35,"is_preprint":false},{"pmid":"26794869","id":"PMC_26794869","title":"The kinase activity of PKR represses inflammasome activity.","date":"2016","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/26794869","citation_count":33,"is_preprint":false},{"pmid":"18971339","id":"PMC_18971339","title":"Protein kinase PKR mutants resistant to the poxvirus pseudosubstrate K3L protein.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18971339","citation_count":33,"is_preprint":false},{"pmid":"29625900","id":"PMC_29625900","title":"ADAR1 and PKR, interferon stimulated genes with clashing effects on HIV-1 replication.","date":"2018","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/29625900","citation_count":32,"is_preprint":false},{"pmid":"27612419","id":"PMC_27612419","title":"nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27612419","citation_count":32,"is_preprint":false},{"pmid":"11752660","id":"PMC_11752660","title":"PACT and PKR: turning on NF-kappa B in the absence of virus.","date":"2001","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/11752660","citation_count":31,"is_preprint":false},{"pmid":"28724458","id":"PMC_28724458","title":"Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism.","date":"2017","source":"Expert reviews in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28724458","citation_count":30,"is_preprint":false},{"pmid":"29906232","id":"PMC_29906232","title":"Novel role of PKR in palmitate-induced Sirt1 inactivation and endothelial cell senescence.","date":"2018","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29906232","citation_count":30,"is_preprint":false},{"pmid":"32539931","id":"PMC_32539931","title":"Hepatitis C virus exploits cyclophilin A to evade PKR.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32539931","citation_count":30,"is_preprint":false},{"pmid":"23990781","id":"PMC_23990781","title":"The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen.","date":"2013","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/23990781","citation_count":29,"is_preprint":false},{"pmid":"21978664","id":"PMC_21978664","title":"Heparin activates PKR by inducing dimerization.","date":"2011","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21978664","citation_count":29,"is_preprint":false},{"pmid":"19715457","id":"PMC_19715457","title":"Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.","date":"2009","source":"Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research","url":"https://pubmed.ncbi.nlm.nih.gov/19715457","citation_count":29,"is_preprint":false},{"pmid":"9735304","id":"PMC_9735304","title":"RNA binding and modulation of PKR activity.","date":"1998","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/9735304","citation_count":29,"is_preprint":false},{"pmid":"33588244","id":"PMC_33588244","title":"EIF2AK2 selectively regulates the gene transcription in immune response and histones associated with systemic lupus erythematosus.","date":"2021","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33588244","citation_count":28,"is_preprint":false},{"pmid":"36869030","id":"PMC_36869030","title":"Polynucleotide phosphorylase protects against renal tubular injury via blocking mt-dsRNA-PKR-eIF2α axis.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36869030","citation_count":27,"is_preprint":false},{"pmid":"10684936","id":"PMC_10684936","title":"A new double-stranded RNA-binding protein that interacts with PKR.","date":"2000","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/10684936","citation_count":27,"is_preprint":false},{"pmid":"7686884","id":"PMC_7686884","title":"Localization of the human interferon-induced, ds-RNA activated p68 kinase gene (PRKR) to chromosome 2p21-p22.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7686884","citation_count":27,"is_preprint":false},{"pmid":"10799709","id":"PMC_10799709","title":"Tissue specific expression of PKR protein kinase in aging B6D2F1 mice.","date":"2000","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/10799709","citation_count":26,"is_preprint":false},{"pmid":"26725122","id":"PMC_26725122","title":"NIPBL Controls RNA Biogenesis to Prevent Activation of the Stress Kinase PKR.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26725122","citation_count":26,"is_preprint":false},{"pmid":"27994435","id":"PMC_27994435","title":"PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression.","date":"2016","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/27994435","citation_count":26,"is_preprint":false},{"pmid":"39311631","id":"PMC_39311631","title":"EIF2AK2 protein targeted activation of AIM2-mediated PANoptosis promotes sepsis-induced acute kidney injury.","date":"2024","source":"Renal failure","url":"https://pubmed.ncbi.nlm.nih.gov/39311631","citation_count":25,"is_preprint":false},{"pmid":"25064266","id":"PMC_25064266","title":"HIV-1 translation and its regulation by cellular factors PKR and PACT.","date":"2014","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/25064266","citation_count":25,"is_preprint":false},{"pmid":"39146181","id":"PMC_39146181","title":"An ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA inhibits PKR activation.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/39146181","citation_count":24,"is_preprint":false},{"pmid":"30518569","id":"PMC_30518569","title":"The Noncoding RNA nc886 Regulates PKR Signaling and Cytokine Production in Human Cells.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30518569","citation_count":24,"is_preprint":false},{"pmid":"26488609","id":"PMC_26488609","title":"Regulation of PKR by RNA: formation of active and inactive dimers.","date":"2015","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26488609","citation_count":24,"is_preprint":false},{"pmid":"33984068","id":"PMC_33984068","title":"Human DICER helicase domain recruits PKR and modulates its antiviral activity.","date":"2021","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/33984068","citation_count":24,"is_preprint":false},{"pmid":"31292248","id":"PMC_31292248","title":"The Leader Protein of Theiler's Virus Prevents the Activation of PKR.","date":"2019","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/31292248","citation_count":24,"is_preprint":false},{"pmid":"28611419","id":"PMC_28611419","title":"Interaction of PKR with single-stranded RNA.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28611419","citation_count":23,"is_preprint":false},{"pmid":"23105000","id":"PMC_23105000","title":"Activation of PKR by RNA misfolding: HDV ribozyme dimers activate PKR.","date":"2012","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23105000","citation_count":22,"is_preprint":false},{"pmid":"27486347","id":"PMC_27486347","title":"Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition.","date":"2016","source":"Biomarkers in cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27486347","citation_count":22,"is_preprint":false},{"pmid":"35970851","id":"PMC_35970851","title":"PKR and TLR3 trigger distinct signals that coordinate the induction of antiviral apoptosis.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35970851","citation_count":21,"is_preprint":false},{"pmid":"12860279","id":"PMC_12860279","title":"Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer.","date":"2003","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/12860279","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42907,"output_tokens":9772,"usd":0.137651,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20427,"output_tokens":5183,"usd":0.115855,"stage2_stop_reason":"end_turn"},"total_usd":0.253506,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"PKR is activated by binding to dsRNA via a mechanism involving autophosphorylation, which then phosphorylates the alpha subunit of eIF2 (eIF2α) to inhibit translation initiation.\",\n      \"method\": \"In vitro kinase assays, cell-based assays with dsRNA activation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro kinase activity, replicated across many independent studies over decades\",\n      \"pmids\": [\"10557102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HCV envelope protein E2 contains a sequence identical to phosphorylation sites of PKR and eIF2α, and directly inhibits PKR kinase activity, blocking its inhibitory effect on protein synthesis and cell growth.\",\n      \"method\": \"In vitro kinase assay, cell-based protein synthesis and growth inhibition assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro kinase inhibition assay plus cell-based functional validation in a single rigorous study\",\n      \"pmids\": [\"10390359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PKR activation by dsRNA requires dimerization: a minimal dsRNA of 30 bp is required to bind two PKR monomers and elicit autophosphorylation; PKR monomers sequentially attach to a single dsRNA and dimerize via kinase domain contacts.\",\n      \"method\": \"Sedimentation velocity analytical ultracentrifugation, autophosphorylation assays with dsRNAs of defined length\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biophysical reconstitution with defined substrates plus functional autophosphorylation assays in a single rigorous study\",\n      \"pmids\": [\"18599071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PKR activation by dsRNA or the cellular protein PACT involves an intramolecular interaction between a PACT-binding motif (PBM) in the kinase domain and the dsRNA-binding domain that keeps PKR inactive; disruption of this interaction by point mutations produces constitutively active PKR.\",\n      \"method\": \"Biochemical assays, NMR analyses, point mutagenesis, genetic complementation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural mapping combined with mutagenesis and functional kinase assays in a single study\",\n      \"pmids\": [\"16785445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystal structures of eIF2α bound to PKR reveal that PKR forms a back-to-back parallel dimer essential for kinase activation, and demonstrate how eIF2α docks to its kinase; activation-loop phosphorylation allosterically couples dimerization and substrate recognition interfaces.\",\n      \"method\": \"X-ray crystallography, mutagenesis analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional mutagenesis validation, complemented by two independent papers (Dar et al. and Dey et al.)\",\n      \"pmids\": [\"16179248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PKR activation requires dimerization-induced cis-phosphorylation at Thr-446 in the activation loop; dimerization precedes and stimulates activation loop autophosphorylation, and these two processes are mutually exclusive yet interdependent.\",\n      \"method\": \"Yeast Saccharomyces cerevisiae model system, PKR bypass mutants, mutagenesis of dimerization-essential residues (Asp-266, Tyr-323), eIF2α phosphorylation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with reconstituted functional assays, multiple orthogonal genetic and biochemical approaches\",\n      \"pmids\": [\"24338483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RNA dimerization promotes PKR dimerization and activation: TAR RNA dimers (effectively doubling dsRNA length from 23 bp to ~46 bp) bind two or three PKR molecules and activate PKR, whereas TAR monomers bind only one PKR monomer and do not activate it.\",\n      \"method\": \"Native gel electrophoresis, analytical ultracentrifugation, autophosphorylation assays, enzymatic structure mapping\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biophysical and biochemical reconstitution with multiple orthogonal methods in a single study\",\n      \"pmids\": [\"19445956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Heparin activates PKR by binding to the kinase domain (not the dsRNA-binding domain) and allosterically enhancing PKR dimerization, demonstrating that PKR can be activated by non-RNA molecules via the kinase domain.\",\n      \"method\": \"Analytical ultracentrifugation, autophosphorylation assays, thermodynamic linkage modeling\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biophysical reconstitution with multiple orthogonal methods establishing mechanism in a single rigorous study\",\n      \"pmids\": [\"21978664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Activating dsRNAs induce a back-to-back parallel PKR kinase dimer required for activation, whereas non-activating RNAs (e.g., containing a 2'-O-methyl barrier) either fail to induce dimerization or produce an alternative inactive dimer configuration.\",\n      \"method\": \"homo-FRET assay for kinase domain dimerization, autophosphorylation assays, mutagenesis of dimer interface residues\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — novel FRET dimerization assay combined with mutagenesis and functional assays, multiple orthogonal approaches\",\n      \"pmids\": [\"26488609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Viral inhibitor RNAs EBER(I) (Epstein-Barr virus) and VA(I) (adenovirus) bind PKR dsRNA-binding domains using similar surfaces as activating RNAs but inhibit PKR activation; regions beyond the stem-loop dsRBD contacts are required for inhibition, demonstrating that dsRNA binding and kinase inactivation are non-equivalent.\",\n      \"method\": \"Isothermal titration calorimetry, gel electrophoresis binding assays, NMR chemical shift perturbation, autophosphorylation assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural mapping combined with biophysical binding measurements and functional kinase assays\",\n      \"pmids\": [\"16580685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKR physically interacts with inflammasome components NLRP3, NLRP1, NLRC4, AIM2, and ASC; PKR autophosphorylation in a cell-free reconstituted system with recombinant NLRP3, ASC, and pro-caspase-1 reconstitutes inflammasome activity, and PKR deficiency severely impairs inflammasome activation and IL-1β/IL-18/HMGB1 secretion.\",\n      \"method\": \"Co-immunoprecipitation, cell-free reconstitution with recombinant proteins, genetic deletion, pharmacological inhibition, in vivo peritonitis model\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cell-free reconstitution plus reciprocal Co-IP plus genetic KO with defined cytokine readouts, multiple orthogonal approaches\",\n      \"pmids\": [\"22801494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PKR is a critical mediator of macrophage apoptosis downstream of TLR4; TLR4-activated PKR promotes apoptosis through inhibition of protein synthesis and activation of interferon response factor 3 (IRF3).\",\n      \"method\": \"Genetic deletion of PKR, epistasis analysis, macrophage apoptosis assays with bacterial pathogens\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined apoptotic phenotype, pathway placement via epistasis, replicated with multiple bacterial pathogens\",\n      \"pmids\": [\"15029200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"During mitosis, PKR is activated in uninfected cells by binding to dsRNAs formed by inverted Alu repeats (IRAlus) when nuclear structure is disrupted; activated PKR phosphorylates eIF2α to suppress global translation, acts as upstream kinase for JNK, and regulates levels of mitotic factors (cyclins A/B, Polo-like kinase 1) and histone H3 phosphorylation.\",\n      \"method\": \"RNAi knockdown, dominant-negative PKR expression, immunofluorescence, Western blot, cell cycle analysis, RNA pulldown\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined mitotic phenotypes, RNA-protein interaction mapping, multiple orthogonal approaches in a single study\",\n      \"pmids\": [\"24939934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PKR interacts with endogenous mitochondrial dsRNAs (mt-dsRNAs) formed by bidirectional transcription of the mitochondrial genome; these mt-dsRNAs regulate PKR and eIF2α phosphorylation to control cell signaling and translation; PKR phosphatases counteract mt-dsRNA-driven PKR activation.\",\n      \"method\": \"Formaldehyde-mediated crosslinking and immunoprecipitation sequencing (fCLIP-seq), Western blot, genetic manipulation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct RNA-protein crosslinking-IP sequencing combined with functional phosphorylation assays, multiple orthogonal methods\",\n      \"pmids\": [\"30174290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss of PRKRA (by mis-splicing caused by TIA1/TIAL1 double knockout) triggers EIF2AK2/PKR activation and stress granule formation; ectopic expression of PRKRA cDNA or knockout of EIF2AK2 in double-knockout cells rescues this phenotype, placing PRKRA as a direct upstream regulator of PKR.\",\n      \"method\": \"Double knockout cell lines, PAR-CLIP, Western blot, genetic rescue experiments\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with double KO and rescue experiments, multiple orthogonal approaches\",\n      \"pmids\": [\"29429924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Cytoplasmic STAT3 directly interacts with EIF2AK2/PKR via the catalytic domain of PKR and the SH2 domain of STAT3 (recapitulated with recombinant proteins in pull-down); STAT3 acts as a competitive inhibitor of PKR-mediated eIF2α phosphorylation; disruption of this complex by STAT3 inhibitors or fatty acids (palmitate) activates PKR-dependent autophagy.\",\n      \"method\": \"Recombinant protein pull-down, Co-IP, overexpression of STAT3 mutants, chemical screen, autophagy flux assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted pull-down with recombinant proteins plus domain-mapping mutants plus functional autophagy assays\",\n      \"pmids\": [\"23221979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ADAR1 dsRBD3 directly interacts with PKR kinase domain on dsRNA to inhibit PKR activation; wild-type or editing-inactive ADAR1 expressed in A549 cells inhibits endogenous PKR, and mutating the ADAR1 dsRBD3-PKR contact prevents co-immunoprecipitation, ADAR1 inhibition of PKR activity, and their co-localization.\",\n      \"method\": \"Co-immunoprecipitation, AlphaFold structural modeling, functional PKR activation assays, mutagenesis of interaction interface, immunofluorescence co-localization\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with mutagenesis validation plus functional kinase assays, multiple orthogonal methods in a single study\",\n      \"pmids\": [\"39146181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ADAR1p150 isoform prevents PKR activation through its dsRNA-binding activity (distinct from its RNA-editing function); deleting both MDA5 and PKR completely rescues embryonic lethality of Adar1p150-/- mice, whereas deleting either alone provides limited or no rescue.\",\n      \"method\": \"Genetic epistasis in mice (Adar1p150-/- × Mavs-/- × Eif2ak2-/- triple mutants), survival analysis, genetic rescue experiments\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous in vivo genetic epistasis with triple-mutant rescue, clearly distinguishes MDA5 vs PKR activation mechanisms\",\n      \"pmids\": [\"37797622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Endogenous circRNAs act as PKR inhibitors by forming 16-26 bp imperfect RNA duplexes that suppress PKR activation; upon viral infection or poly(I:C) stimulation, RNase L degrades circRNAs, which is required for PKR activation in early innate immune responses.\",\n      \"method\": \"CircRNA overexpression/depletion, RNase L functional assays, PKR phosphorylation assays, viral infection experiments\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reconstitution with circRNA manipulation combined with multiple orthogonal cellular assays\",\n      \"pmids\": [\"31031002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"mRNAs containing uridine activate PKR which phosphorylates eIF2α and inhibits translation; mRNAs with pseudouridine substitutions activate PKR to a lesser degree, bind PKR less efficiently (by RNA pull-down), and are translated equally in PKR knockout cells.\",\n      \"method\": \"RNA pull-down assay, PKR phosphorylation assay, PKR knockout cell translation assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-protein binding assay plus functional translation assay in PKR-KO cells, multiple orthogonal approaches\",\n      \"pmids\": [\"20457754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Vaccinia virus K3L protein acts as a pseudosubstrate inhibitor of PKR; the K3L protein co-immunoprecipitates with PKR in vaccinia virus-infected cells, and its inhibitory function depends critically on residues near its C-terminus that share a sequence motif with eIF2α.\",\n      \"method\": \"Co-immunoprecipitation in infected cells, yeast growth inhibition assay, cell-free translation assay, mutagenesis\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus yeast genetic assay plus cell-free functional assay, multiple orthogonal approaches\",\n      \"pmids\": [\"11040133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Positive selection of specific residues near the eIF2α-binding site on the C-terminal lobe of PKR kinase domain governs sensitivity to poxviral pseudosubstrate inhibitors; substitution of positively selected residues altered species-specific sensitivity to K3L and related poxviral inhibitors without impairing eIF2α phosphorylation.\",\n      \"method\": \"Evolutionary analysis, site-directed mutagenesis, yeast-based PKR function assay, in vitro kinase assay\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with functional kinase assays and yeast genetic system in a single rigorous study\",\n      \"pmids\": [\"19043413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Mutations in the C-terminal lobe of the PKR kinase domain confer resistance to vaccinia K3L pseudosubstrate inhibitor (e.g., PKR-D486V shows ~15-fold decreased K3L binding) while leaving eIF2α phosphorylation intact, mapping the eIF2α-binding site to an extensive face of the C-terminal lobe.\",\n      \"method\": \"Yeast-based PKR toxicity screen, in vitro kinase assay, binding affinity measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis screen plus in vitro binding and kinase assays, multiple orthogonal approaches\",\n      \"pmids\": [\"18971339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HCV NS5A protein colocalizes with PKR and suppresses dsRNA activation of PKR during HCV RNA replication; mutations in the PKR-binding domain of NS5A relieved this blockade, resulting in IRF-1 activation and reduced HCV replication.\",\n      \"method\": \"Colocalization studies, PKR activation assays, NS5A mutagenesis, HCV replicon system, IRF-1 reporter assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct colocalization plus domain-mapping mutagenesis plus functional viral replication assays\",\n      \"pmids\": [\"11904369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PKR acts as a molecular clock: its catalysis-independent activity activates NF-κB survival signaling to delay apoptosis, while its kinase activity (phosphorylation of eIF2α) subsequently induces cell death, temporally separating survival and death programs.\",\n      \"method\": \"Kinase-dead PKR mutants, NF-κB reporter assays, apoptosis assays, eIF2α phosphorylation measurements\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase-dead mutant analysis dissecting catalytic vs. structural functions, multiple functional readouts\",\n      \"pmids\": [\"14749731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PKR is a critical upstream mediator of the ribotoxic stress response: DON (deoxynivalenol) rapidly induces PKR autophosphorylation and eIF2α phosphorylation within 1-5 min, and PKR deficiency (via antisense expression) markedly suppresses downstream MAPK (JNK > p38 > ERK) phosphorylation and apoptosis.\",\n      \"method\": \"PKR inhibitor pretreatment, antisense PKR stable transformants, MAPK phosphorylation assays, apoptosis assays\",\n      \"journal\": \"Toxicological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — PKR-deficient cell line plus pharmacological inhibition with defined pathway readouts, multiple orthogonal approaches\",\n      \"pmids\": [\"12773753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PKR directly binds and phosphorylates monomeric and filamentous α-synuclein on Ser129 in vitro; overexpression of constitutively active PKR increases Ser129 α-synuclein phosphorylation, while inhibition/knockdown of PKR reduces it in multiple cell models and primary neurons.\",\n      \"method\": \"In vitro phosphorylation assay, PKR inhibitor treatment, PKR siRNA knockdown, PKR overexpression, multiple cell models and acute brain slices\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro kinase-substrate assay plus loss- and gain-of-function in multiple independent cellular systems\",\n      \"pmids\": [\"29501855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PKR forms cytosolic condensates (dsRNA-induced foci, dRIFs) in response to increased endogenous or exogenous dsRNA; dRIFs contain dsRNA, enrich dsRNA-binding proteins (ADAR1, Stau1, NLRP1, PACT), form before translation repression, and localize to regions where PKR activation is initiated; disruption of PKR clusters enhances eIF2α phosphorylation.\",\n      \"method\": \"Live-cell imaging, immunofluorescence, co-localization studies, eIF2α phosphorylation assays, dsRNA length-dependence experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with functional consequence (cluster disruption enhances phosphorylation), single lab with multiple orthogonal imaging and biochemical approaches\",\n      \"pmids\": [\"35939694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PKR signaling involves assembly of dynamic PKR clusters driven by ligand binding and front-to-front interfaces between kinase domains; eIF2α is not recruited to PKR clusters, and PKR cluster disruption enhances eIF2α phosphorylation, suggesting clusters buffer downstream signaling.\",\n      \"method\": \"Live-cell fluorescence microscopy, genetic manipulation, eIF2α phosphorylation assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct imaging of PKR dynamics with functional consequence measured, single lab\",\n      \"pmids\": [\"35522180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PKR kinase activity represses (not activates) cryopyrin/NLRP3 inflammasome activity by inhibiting protein translation of inflammasome constituents to prevent initial priming during innate immune signaling, as demonstrated by a knock-in mouse expressing kinase-dead PKR.\",\n      \"method\": \"Kinase-dead knock-in mouse, PKR-null mouse, inflammasome activation assays, translation inhibition measurements\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent transgenic mouse models (kinase-dead knock-in and null), with defined mechanistic pathway (translation inhibition of inflammasome components), directly contradicts earlier reports\",\n      \"pmids\": [\"26794869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PKR is activated by CD40 ligation via TRAF6 and TRAF2: TRAF6 co-immunoprecipitates with PKR upon CD40 ligation, TRAF2 bridges TRAF6 and PKR, and PKR activation promotes autophagy and LC3 accumulation around Toxoplasma gondii vacuoles for parasite killing.\",\n      \"method\": \"Co-immunoprecipitation, TRAF2-deficient cells, PKR-null mice, autophagy assays, vacuole-lysosomal fusion assays, parasite killing assays\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with defined pathway components plus functional KO phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"23990781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PKR promotes G3BP1 foci formation via an RNA-dependent association, which is necessary for cGAS condensation and cGAS-dependent interferon responses to intracellular DNA.\",\n      \"method\": \"Co-immunoprecipitation, loss-of-function (G3BP1 and PKR knockdown), interferon response assays, immunofluorescence\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional knockdown with defined innate immune readout plus Co-IP, single lab\",\n      \"pmids\": [\"31772125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RAN translation from structured CAG, CCUG, CAGG, and G4C2 expansion RNAs is regulated by PKR; blocking PKR via dominant-negative PKR-K296R, TRBP overexpression, or PKR-KO reduces RAN protein levels; inhibiting PKR in C9orf72 BAC transgenic mice with AAV-PKR-K296R or metformin decreases RAN proteins and improves behavior.\",\n      \"method\": \"PKR-KO cells, dominant-negative PKR expression, PKR inhibitors, in vivo AAV delivery, C9orf72 BAC transgenic mouse model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent loss-of-function approaches (KO, dominant-negative, pharmacological) plus in vivo animal model validation\",\n      \"pmids\": [\"32690681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"EIF2AK2/PKR bridges YTHDF3 and eIF3A, enhancing the stability of the YTHDF3/eIF3A complex in oxaliplatin-resistant colorectal cancer cells to facilitate translation of m6A-methylated mRNAs.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, functional translation assays\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP experiment, single lab, no mechanistic mutagenesis or reconstitution\",\n      \"pmids\": [\"35708211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Berberine directly binds EIF2AK2 (via two ionic bonds by chemoproteomic analysis), subtly inhibits EIF2AK2 dimerization rather than its enzyme activity, and selectively modulates downstream JNK, NF-κB, AKT, and NLRP3 pathways; EIF2AK2 knockdown attenuates berberine's anti-inflammatory effects in vivo.\",\n      \"method\": \"Chemoproteomic target identification, binding affinity measurements, EIF2AK2 knockdown mice, cytokine assays, dimerization assays\",\n      \"journal\": \"Acta pharmaceutica Sinica B\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chemoproteomic target ID plus in vivo genetic validation plus dimerization assay, multiple orthogonal approaches, single lab\",\n      \"pmids\": [\"37250154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"APOBEC3B forms a complex with PABPC1 to stimulate PKR and counterbalances PKR-suppressing activity of ADAR1 during viral infection, promoting translational blockage and stress granule formation; APOBEC3B localizes to stress granules through its interaction with PABPC1.\",\n      \"method\": \"Co-immunoprecipitation, loss-of-function studies, eIF2α phosphorylation assays, stress granule imaging, viral infection experiments\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP defining complex plus multiple functional assays, single lab\",\n      \"pmids\": [\"36781883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"EIF2AK2 directly targets and positively regulates AIM2 expression; Co-IP demonstrates direct binding between EIF2AK2 and AIM2, and EIF2AK2 induces PANoptosis through upregulating AIM2 in LPS-treated renal tubular cells.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, siRNA knockdown, LPS-stimulated cell model\",\n      \"journal\": \"Renal failure\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP with limited mechanistic follow-up, single lab\",\n      \"pmids\": [\"39311631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Reduction of PNPT1 leads to leakage of mitochondrial dsRNA into cytoplasm where it activates PKR, causing eIF2α phosphorylation and translational arrest leading to renal tubular atrophy; inhibiting PKR rescues ischemia-reperfusion or ureteral obstruction-induced renal tubular injury in mice.\",\n      \"method\": \"PNPT1 knockout mice, PKR inhibitor treatment, Western blot, in vivo mouse models, histopathology\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus pharmacological inhibition plus in vivo rescue, multiple orthogonal approaches, independently replicated pathway\",\n      \"pmids\": [\"36869030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Human DICER helicase domain directly interacts with PKR (enriched by proteomics during viral infection); deletion of the DICER helicase domain confers antiviral properties in an RNAi-independent, PKR-dependent manner.\",\n      \"method\": \"Proteomics/interactome analysis, domain-deletion mutants, viral replication assays, PKR-dependency genetic experiments\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomics-based interaction plus genetic domain deletion with PKR-dependent functional readout, single lab\",\n      \"pmids\": [\"33984068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EIF2AK2 missense variants (p.Gly130Arg, p.Gly138Ala, p.Asn32Thr) found in dystonia patients show abnormally enhanced PKR-mediated phosphorylation of eIF2α in patient-derived fibroblasts, demonstrating gain-of-function kinase activity.\",\n      \"method\": \"Patient-derived fibroblast studies, Western blot for eIF2α phosphorylation, Sanger sequencing\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived cell functional assays confirming gain-of-function, single lab, limited mechanistic follow-up\",\n      \"pmids\": [\"33236446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EIF2AK2 missense variants associated with neurodevelopmental syndrome show reduced kinase activity in mammalian cell lines and proband-derived fibroblasts, linking deficient eIF2α phosphorylation to the disease phenotype.\",\n      \"method\": \"Mammalian cell line transfection, patient-derived fibroblast functional assays, Western blot for eIF2α phosphorylation\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional kinase assays in patient-derived cells, single lab, limited mechanistic depth\",\n      \"pmids\": [\"32197074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PKR activation in TNF-α-stimulated chondrocytes triggers PKC phosphorylation, which activates NADPH oxidase leading to oxidative stress; this cascade activates COX-2 and IL-8 via ERK/NF-κB pathway and impedes PPAR-γ-mediated inhibition of MMP-13.\",\n      \"method\": \"PKR activation with poly(I:C), PKR/PKC pathway inhibitors, Western blot, NADPH oxidase activity assay, OA patient cartilage\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway dissection with multiple signaling readouts, single lab\",\n      \"pmids\": [\"28869834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In PKR-null colonic epithelial cells during DSS colitis, eIF2α phosphorylation-mediated unfolded protein response (UPR), ER chaperone response, ERAD, and antioxidative stress response are impaired, as are STAT3 and AKT phosphorylation, demonstrating PKR's role in coordinating multiple pro-survival signaling pathways in epithelial cells.\",\n      \"method\": \"PKR-null mice with bone marrow reconstitution, DSS colitis model, Western blot for pathway components\",\n      \"journal\": \"Inflammatory bowel diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic KO with defined cellular phenotype and multiple biochemical readouts, single lab\",\n      \"pmids\": [\"22275310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The PRKR (EIF2AK2) gene was mapped to human chromosome 2p21-p22 and mouse chromosome 17 E2 using somatic cell hybrids and fluorescence in situ hybridization.\",\n      \"method\": \"Somatic cell hybrid panel, fluorescence in situ hybridization (FISH)\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — independent chromosomal mapping by two groups using orthogonal methods (FISH and somatic cell hybrids), replicated\",\n      \"pmids\": [\"7686883\", \"7686884\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EIF2AK2/PKR is an interferon-inducible serine/threonine kinase that senses dsRNA (viral or endogenous, including mitochondrial dsRNA and inverted-Alu repeat-containing RNAs) via its N-terminal dsRNA-binding domain; dsRNA binding drives back-to-back kinase-domain dimerization and cis-autophosphorylation at Thr-446 in the activation loop, activating PKR to phosphorylate eIF2α on Ser-51, thereby globally inhibiting translation initiation; activated PKR also directly phosphorylates α-synuclein on Ser-129, interacts with inflammasome components (NLRP3, NLRP1, NLRC4, AIM2, ASC) to regulate inflammasome assembly, activates NF-κB in a kinase-independent manner, acts upstream of JNK/p38/ERK MAPKs, promotes apoptosis via IRF3 and FADD/caspase-8, and is regulated by multiple binding partners (PACT activates; TRBP, ADAR1, STAT3, nc886, and circRNAs inhibit) as well as by dynamic cytosolic condensate formation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"EIF2AK2/PKR is a dsRNA-activated serine/threonine kinase that couples detection of double-stranded RNA to global translational control and innate immune signaling [#0]. Activation is conformational and dimerization-dependent: an inhibitory intramolecular contact between a kinase-domain motif and the dsRNA-binding domain keeps PKR latent, and dsRNA binding relieves this autoinhibition by recruiting two monomers onto a single duplex (minimally ~30 bp) to drive back-to-back kinase-domain dimerization [#2, #3, #4]. Dimerization triggers cis-autophosphorylation at Thr-446 in the activation loop, allosterically coupling the dimerization and substrate interfaces so that activated PKR phosphorylates eIF2\\u03b1 to block translation initiation [#4, #5]. The duplex length and structure of the activating RNA dictate productive dimer geometry, and PKR can also be activated through its kinase domain by non-RNA ligands such as heparin, indicating that dimerization\\u2014not nucleic-acid binding per se\\u2014is the activating event [#6, #7, #8]. Beyond viral dsRNA, PKR senses endogenous ligands including inverted-Alu repeat RNAs exposed during mitosis and mitochondrial dsRNA released upon loss of mitochondrial RNA turnover, linking it to cell-cycle translational suppression and to renal tubular injury [#12, #13, #37]. PKR also functions as a substrate kinase beyond eIF2\\u03b1, directly phosphorylating \\u03b1-synuclein on Ser-129 [#26]. Functionally, PKR is an apoptotic and inflammatory effector: it mediates macrophage death downstream of TLR4 via IRF3 [#11], drives ribotoxic-stress MAPK signaling (JNK/p38/ERK) and apoptosis [#25], and acts as a temporal switch using kinase-independent NF-\\u03baB survival signaling versus kinase-dependent eIF2\\u03b1-mediated death [#24]. Its activity is tightly set by competing regulators\\u2014PACT/PRKRA and APOBEC3B-PABPC1 promote activation, while STAT3, ADAR1, and endogenous circRNAs inhibit it\\u2014and viral antagonists (HCV E2 and NS5A, vaccinia K3L pseudosubstrate, EBER/VA-I RNAs) suppress PKR to evade the antiviral response [#1, #3, #9, #14, #15, #16, #18, #20, #23, #35]. Spatially, dsRNA induces cytosolic PKR condensates that organize and buffer downstream eIF2\\u03b1 phosphorylation [#27, #28]. Bidirectional EIF2AK2 missense variants cause neurological disease: gain-of-function alleles with enhanced eIF2\\u03b1 phosphorylation underlie dystonia, while loss-of-function alleles cause a neurodevelopmental syndrome [#39, #40].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing the human and mouse chromosomal location of EIF2AK2 provided the genomic anchor for subsequent functional and genetic study.\",\n      \"evidence\": \"Somatic cell hybrid panels and FISH mapping to human 2p21-p22 and mouse chromosome 17 E2\",\n      \"pmids\": [\"7686883\", \"7686884\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mapping alone established no function\", \"No gene structure or regulatory elements defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defining the core enzymatic logic\\u2014dsRNA binding triggers autophosphorylation, which enables eIF2\\u03b1 phosphorylation and translational shutdown\\u2014answered what PKR does at the molecular level.\",\n      \"evidence\": \"In vitro kinase assays and dsRNA-activated cell-based assays\",\n      \"pmids\": [\"10557102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of dsRNA-driven activation not resolved\", \"Stoichiometry of activation undefined at this stage\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Crystal structures of the PKR\\u2013eIF2\\u03b1 complex revealed back-to-back parallel dimerization as the activation mechanism and showed how substrate docks, settling how activation and substrate recognition are coupled.\",\n      \"evidence\": \"X-ray crystallography with mutagenesis validation\",\n      \"pmids\": [\"16179248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not show how dsRNA length controls dimer geometry\", \"Did not resolve the autoinhibited latent state\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Biophysical reconstitution established that dimerization is the activating event\\u2014a minimal ~30 bp duplex binds two monomers\\u2014distinguishing RNA binding from kinase activation.\",\n      \"evidence\": \"Analytical ultracentrifugation and length-defined autophosphorylation assays; complemented by RNA-dimerization and pseudosubstrate residue studies\",\n      \"pmids\": [\"18599071\", \"19445956\", \"18971339\", \"19043413\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In-cell relevance of minimal duplex thresholds untested at the time\", \"Did not address non-RNA activators\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying an intramolecular autoinhibitory contact between the kinase domain and dsRNA-binding domain explained how PKR is held latent and how PACT and dsRNA relieve inhibition.\",\n      \"evidence\": \"NMR mapping, point mutagenesis yielding constitutively active PKR, genetic complementation; inhibitory RNAs (EBER/VA-I) shown to bind but not activate\",\n      \"pmids\": [\"16785445\", \"16580685\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of autoinhibition to basal control unclear\", \"How specific ligands tip the equilibrium not fully resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating that dimerization drives cis-autophosphorylation specifically at Thr-446 ordered the activation steps mechanistically.\",\n      \"evidence\": \"Yeast genetic system with bypass and dimerization-interface mutants and eIF2\\u03b1 phosphorylation readouts; FRET dimerization assay distinguishing activating vs non-activating RNAs (2015)\",\n      \"pmids\": [\"24338483\", \"26488609\", \"21978664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetics of dimer-to-phosphorylation transition in cells incompletely defined\", \"Alternative inactive dimer states only partially characterized\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Separating kinase-independent NF-\\u03baB survival signaling from kinase-dependent eIF2\\u03b1-mediated death established PKR as a temporal apoptotic switch and a node beyond translation control.\",\n      \"evidence\": \"Kinase-dead mutants with NF-\\u03baB reporter and apoptosis assays; TLR4-IRF3 apoptosis epistasis in macrophages\",\n      \"pmids\": [\"14749731\", \"15029200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct NF-\\u03baB activation mechanism not molecularly defined\", \"How the same kinase routes to survival vs death contextually unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Placing PKR upstream of the MAPK ribotoxic stress response connected dsRNA-independent stress to JNK/p38/ERK and apoptosis.\",\n      \"evidence\": \"PKR-deficient (antisense) cells and inhibitor pretreatment with MAPK and apoptosis readouts; chondrocyte PKC/NADPH-oxidase cascade\",\n      \"pmids\": [\"12773753\", \"28869834\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PKR substrates linking to MAPK activation not identified\", \"Distinction from eIF2\\u03b1-dependent effects incomplete\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linking PKR physically and functionally to inflammasome assembly extended its role into innate cytokine output, though the directionality of this control was later contested.\",\n      \"evidence\": \"Co-IP with NLRP3/NLRP1/NLRC4/AIM2/ASC, cell-free reconstitution, and KO with cytokine readouts (2012) versus kinase-dead/null knock-in mice showing kinase activity represses NLRP3 (2016)\",\n      \"pmids\": [\"22801494\", \"26794869\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The 2012 promoting role and 2016 repressing role are not reconciled\", \"Context-dependence (priming vs assembly) not fully delineated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying competing protein regulators (STAT3, PACT/PRKRA, ADAR1, APOBEC3B-PABPC1) defined how PKR's activation threshold is tuned in the absence of pathogen.\",\n      \"evidence\": \"Recombinant pull-downs, domain-mapping, Co-IP with mutagenesis, genetic rescue/epistasis, and in vivo triple-mutant mouse rescue\",\n      \"pmids\": [\"23221979\", \"29429924\", \"16785445\", \"39146181\", \"37797622\", \"36781883\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hierarchy and competition among regulators in vivo not quantified\", \"Cell-type-specific dominance of inhibitors vs activators unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showing that endogenous dsRNAs (inverted-Alu repeats during mitosis, mitochondrial dsRNA) activate PKR established a self-RNA sensing role with cell-cycle and tissue-injury consequences.\",\n      \"evidence\": \"RNAi/dominant-negative with cell-cycle readouts; fCLIP-seq of mt-dsRNA; PNPT1-KO and PKR-inhibitor renal injury rescue in mice\",\n      \"pmids\": [\"24939934\", \"30174290\", \"36869030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Triggers gating self-RNA exposure not fully mapped\", \"Phosphatase counter-regulation of mt-dsRNA-driven PKR only partly characterized\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying \\u03b1-synuclein Ser-129 as a direct PKR substrate expanded the kinase's substrate repertoire beyond eIF2\\u03b1 into neurodegeneration-relevant biology.\",\n      \"evidence\": \"In vitro kinase-substrate assay plus loss- and gain-of-function across multiple cell models and brain slices\",\n      \"pmids\": [\"29501855\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo contribution to synucleinopathy not established here\", \"Whether activation route differs from canonical dsRNA sensing unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovering ligand-driven PKR cytosolic condensates (dRIFs/clusters) added a spatial layer in which clustering organizes activation yet buffers downstream eIF2\\u03b1 phosphorylation.\",\n      \"evidence\": \"Live-cell imaging, co-localization, and cluster-disruption phosphorylation assays; G3BP1/cGAS condensation coupling\",\n      \"pmids\": [\"35939694\", \"35522180\", \"31772125\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab imaging-based mechanism awaits orthogonal validation\", \"Molecular determinants of condensate assembly and dissolution undefined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Bidirectional EIF2AK2 disease variants demonstrated that both excess and deficient kinase activity are pathogenic, linking eIF2\\u03b1-phosphorylation dosage to human neurological disease.\",\n      \"evidence\": \"Patient-derived fibroblast and transfection eIF2\\u03b1-phosphorylation assays for gain-of-function (dystonia) and loss-of-function (neurodevelopmental syndrome) variants\",\n      \"pmids\": [\"33236446\", \"32197074\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting altered kinase output to specific phenotypes unresolved\", \"Single-lab functional characterization with limited mechanistic depth\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PKR discriminates self from non-self dsRNA in vivo, and how condensate dynamics, competing regulators, and contradictory inflammasome roles are integrated into a unified activation set-point, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No quantitative model reconciling promoting vs repressing inflammasome roles\", \"Spatial condensate control of signaling lacks structural mechanism\", \"Self-RNA gating thresholds not defined across tissues\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 5, 26]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 4, 5, 26]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 2, 6, 12, 13, 19]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [15, 27, 28]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 11, 18, 30]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 19]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [11, 24, 25]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [25, 13, 37]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [15, 30]}\n    ],\n    \"complexes\": [\"NLRP3 inflammasome\"],\n    \"partners\": [\"EIF2S1\", \"PRKRA\", \"STAT3\", \"ADAR1\", \"NLRP3\", \"ASC\", \"TRAF6\", \"G3BP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":10,"faith_total":10,"faith_pct":100.0}}